SP1 and gastric cancer: We concluded that enhanced SP1 expression was positively associated with unsatisfactory prognosis of various types of cancers including HCC, gastric cancer, pancreatic cancer and esophageal cancer (HR = 1.95; 95%CI:1.16-3.28; p < 0.05) (Figure 3B).